The latest report by IMARC Group, titled “Defibrillators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” finds that the global defibrillators market size reached US$ 5.1 Billion in 2022. Defibrillators are life-saving medical devices used to deliver a therapeutic shock to the heart in case of life-threatening conditions in patients. They deliver shocks through paddles and electrode pads, which restore abnormal heart rhythms during unexpected cardiac arrest. They also depolarize the heart muscles and restore the normal electric impulse. In addition, defibrillators perform cardioversion and pacing of the heart during ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. In recent years, defibrillators have gained immense traction during the ongoing coronavirus disease (COVID-19) pandemic to improve defibrillation delivery measures adopted by healthcare workers and decrease the delay of COVID-19 resuscitation efforts.
Global Defibrillators Market Trends:
The global defibrillators market is driven by the rising incidences of cardiac disorders, diabetes, atherosclerosis, stroke, and hypertension, especially among the rapidly growing geriatric population. Besides this, there has been an increasing adoption of implantable cardioverter defibrillators (ICDs) integrated with innovative subcutaneous and transvenous patches, which aid in improving the overall efficiency and level of comfort for the patient. In addition to this, governments across various countries are taking initiatives to focus on providing public-access defibrillators. They are also supporting awareness campaigns regarding the importance of good cardiac health, which is propelling the market growth. Furthermore, extensive investments in the healthcare sector to develop technologically advanced devices with extended longevity are also fueling the market. On account of these factors, the market is expected to grow at a CAGR of 6.6% during 2023-2028.
- Based on the product type, the market has been segmented into implantable defibrillators [transvenous implantable cardioverter-defibrillator (T-ICDs), subcutaneous implantable cardioverter-defibrillator (S-ICDs), and cardiac resynchronization therapy defibrillator (CRT-D)] and external defibrillators [manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs)].
- On the basis of the end user, the market has been classified into hospitals and clinics, prehospital care settings, cardiac centers, homecare settings, and others.
- Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has been examined, with some of the key players being Asahi Kasei Zoll Medical Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., and Stryker Corporation.
|Base Year of the Analysis
||Product Type, End-User, Region
||North America, Asia Pacific, Europe, Latin America, Middle East and Africa
||United States, Canada, China, Japan, India, South Korea, Australia, Indonesia, Germany, France, United Kingdom, Italy, Spain, Russia Brazil, Mexico
||Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and Stryker Corporation
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800